Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy

Antiepileptic drugs that can reduce aberrant metabolism are beneficial for patients. Zonisamide (ZNS) is a chemical with antiepileptic and antioxidant activities. Here, we evaluate the efficacy of ZNS therapy on reducing obesity and decreasing risks of vascular diseases and hepatic steatosis. Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chi-Ren, Chuang, Hung-Yi, Chen, Nai-Ching, Chen, Shu-Fang, Hsu, Chung-Yao, Chuang, Yao-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347271/
https://www.ncbi.nlm.nih.gov/pubmed/34362163
http://dx.doi.org/10.3390/jcm10153380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347271/
https://www.ncbi.nlm.nih.gov/pubmed/34362163
http://dx.doi.org/10.3390/jcm10153380

Ejemplares similares